WCN 2026 28 - 31 March 2026

Real-world effectiveness of semaglutide and SGLT-2i vs SGLT-2i alone on kidney and cardiovascular outcomes in people with type 2 diabetes and chronic kidney disease

Authors :

Edouard L. Fu, Peter Bruun-Rasmussen, David Cherney, Christine Fuchs Jacobsen, Carolien C. H. M. Maas, Manuel Maximilian Mayrdorfer, Alex Mourer, Brendon Neuen, Nils Skajaa, Katherine Tuttle

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Chronic Kidney Disease

Congress poster

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Real-world effectiveness of semaglutide and SGLT-2i vs SGLT-2i alone on kidney and cardiovascular outcomes in people with type 2 diabetes and chronic kidney disease